Susvimo (ranibizumab injection), 100mg/mL, sold together as a) carton containing One Susvimo recall — FDA D-0025-2023
Defective Delivery System: Commercial implants do not meet the filed specification for the intended use, a few patients have experienced an issue with the implants that renders it…